Full Text View
Tabular View
No Study Results Posted
Related Studies
GTA-Glyceryltriacetate for Canavan Disease
This study is ongoing, but not recruiting participants.
Study NCT00278707   Information provided by Sheba Medical Center
First Received: January 15, 2006   Last Updated: August 11, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infantile Canavan Disease
Deficiency Disease, Aspartoacylase
Additional conditions recognized in this trial
Canavan Disease
Deficiency Diseases
More general conditions related to this trial
Demyelinating Diseases
Genetic Diseases, Inborn
Hereditary Central Nervous System Demyelinating Diseases
Heredodegenerative Disorders, Nervous System
Malnutrition
Nervous System Diseases
Neurodegenerative Diseases
Nutrition Disorders
Interventions listed in this trial
GTA: Glyceryltriacetate
Sponsors listed in this trial
Sheba Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services